Cargando…

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

BACKGROUND: Due to experimental batch effects, the application of a quantitative transcriptional signature for disease diagnoses commonly requires inter-sample data normalization, which would be hardly applicable under common clinical settings. Many cancers might have qualitative differences with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Qingzhou, Yan, Haidan, Chen, Yanhua, Zheng, Baotong, Cai, Hao, He, Jun, Song, Kai, Guo, You, Ao, Lu, Liu, Huaping, Zhao, Wenyuan, Wang, Xianlong, Guo, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789529/ https://www.ncbi.nlm.nih.gov/pubmed/29378509 http://dx.doi.org/10.1186/s12864-018-4446-y

Ejemplares similares

Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
por: He, Jun, et al.
Publicado: (2019)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
por: Guan, Qingzhou, et al.
Publicado: (2021)

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings
por: Liu, Huaping, et al.
Publicado: (2017)

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
por: Yan, Haidan, et al.
Publicado: (2019)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
por: Li, Yawei, et al.
Publicado: (2019)

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes
por: Cai, Hao, et al.
Publicado: (2019)

The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome
por: Guan, Qingzhou, et al.
Publicado: (2020)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
por: He, Jun, et al.
Publicado: (2017)

Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis
por: Yan, Haidan, et al.
Publicado: (2017)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples
por: Chen, Rou, et al.
Publicado: (2016)

Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumors
por: Cheng, Jun, et al.
Publicado: (2018)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer
por: Fu, Yelin, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon Cancer
por: You, Tianyi, et al.
Publicado: (2020)

Two novel qualitative transcriptional signatures robustly applicable to non‐research‐oriented colorectal cancer samples with low‐quality RNA
por: Cheng, Jun, et al.
Publicado: (2021)

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
por: Guo, You, et al.
Publicado: (2016)

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
por: Tong, Mengsha, et al.
Publicado: (2015)

Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues
por: Yan, Haidan, et al.
Publicado: (2017)

A rank-based algorithm of differential expression analysis for small cell line data with statistical control
por: Li, Xiangyu, et al.
Publicado: (2017)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms
por: Guan, Qingzhou, et al.
Publicado: (2016)

Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites
por: Cheng, Jun, et al.
Publicado: (2017)

A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources
por: Zhao, Wenyuan, et al.
Publicado: (2016)

A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
por: Li, Xiang, et al.
Publicado: (2020)

Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings
por: Cai, Hao, et al.
Publicado: (2018)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
por: Chen, Rou, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
por: Liu, Yixin, et al.
Publicado: (2019)

lncRNA pair as candidate diagnostic signature for colorectal cancer based on the within-sample relative expression levels
por: Wang, Ouxi, et al.
Publicado: (2022)

Identification of Genes Universally Differentially Expressed in Gastric Cancer
por: Shi, Yidan, et al.
Publicado: (2021)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients
por: Li, Jing, et al.
Publicado: (2020)

A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer
por: Li, Na, et al.
Publicado: (2020)

Identification of population-level differentially expressed genes in one-phenotype data
por: Xie, Jiajing, et al.
Publicado: (2020)

Identification of Common and Subtype-Specific Mutated Sub-Pathways for a Cancer
por: Yan, Haidan, et al.
Publicado: (2019)

A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas
por: Li, Xin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5931nj09a2nghl5r5marbh4qkf